CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
Endovascular Aortic Aneurysm Repair (Endologix Fenestrated Stent Graft System)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01348828
NCT01348828N/ACompleted

Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms

Endologix·interventional·Posted May 5, 2011·Updated Oct 15, 2021

In Brief

A clinical study evaluating Endovascular Aortic Aneurysm Repair (Endologix Fenestrated Stent Graft System) for Abdominal Aortic Aneurysm. Completed, enrolled 49 participants across 8 sites in 6 countries.

Detailed Summary

The aim of this study is to evaluate the safety and feasibility of the Endologix Fenestrated Stent Graft System for the endovascular repair of juxtarenal or pararenal aortic aneurysms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChile, France, Netherlands, New Zealand, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 5, 2011
Enrollment StartOct 19, 2011
Primary CompletionMay 1, 2013
Study CompletionMar 20, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 15.2 years ago

Interventions

Endovascular Aortic Aneurysm Repair (Endologix Fenestrated Stent Graft System)device

Endovascular repair of juxtarenal or pararenal aortic aneurysm using the Endologix Fenestrated Stent Graft System